profit from every ₹100 of sales.
₹0₹100
Bayer CropScience
₹3,473.70-3.61% today
-20.6% in 1 year
1-year low ₹3,249.901-year high ₹4,989.50
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2026.
0%20% a year
You pay ₹22.65 for every ₹1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Bayer CropScience sold, what it kept, and what it did with the cash.
Sales went from ₹49.4 billion in 2023 to ₹56.8 billion in 2026, with ₹6.89 billion of profit last year.
SalesProfit
Bayer CropScience handed back 56% of the cash it generated last year.
₹5.6B
Free cash flow 2026₹10.1B
Bought back its own shares–
Paid as dividends₹5.6B
Cash vs. debt₹14.1B vs. ₹818M
Bayer CropScience vs. similar companies
Bayer CropScience grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from ₹100 of sales | Sales growth a year | Price per ₹1 of profit |
|---|---|---|---|
| Bayer CropScience | 22.7× · Fair price | ||
 Nutrien | 14.9× · Cheap | ||
 CF Industries Holdings | 12.6× · Cheap | ||
 Industries Qatar Q.P.S.C. | 14.8× · Cheap | ||
 Qinghai Salt Lake Industry Co.,Ltd | 13.6× · Cheap |
AI analysis
An AI analyst reads Bayer CropScience's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 49,449 | 48,921 | 54,734 | 56,750 | |
| 20,932 | 19,490 | 20,746 | 22,975 | |
| 8,598 | 9,085 | 6,047 | 7,797 | |
| 10,919 | 10,350 | 8,093 | 9,687 | |
| 7,582 | 7,405 | 5,680 | 6,892 | |
| 168.71 | 164.77 | 126.38 | – | |
| 42.3% | 39.8% | 37.9% | 40.5% | |
| 17.4% | 18.6% | 11.0% | 13.7% | |
| 15.3% | 15.1% | 10.4% | 12.1% |
Balance sheet
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Total assets | 46,786 | 45,971 | 52,459 | 56,994 |
| Cash | 8,608 | 11,568 | 8,855 | 14,146 |
| Total debt | 735 | 471 | 1,051 | 818 |
| Total liabilities | 19,665 | 17,477 | 23,955 | 27,337 |
| 27,121 | 28,494 | 28,504 | 29,657 | |
| 45 | 45 | 45 | – | |
| 27.3% | 24.9% | 18.4% | 21.5% | |
| 28.0% | 26.0% | 19.9% | 23.2% |
Cash flow
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 6,093 | 9,516 | 2,620 | 10,785 | |
| 773 | 457 | 434 | 645 | |
| 5,320 | 9,059 | 2,186 | 10,140 | |
| Dividends paid | 5,611 | 6,067 | 5,608 | 5,628 |
| – | – | – | – | |
| – | – | – | – |
Valuation
- 22.7×
- –
- –
- 6.4×
- 2.8×
- 15.4×
- 14.7×
- 6.5%
- 4.4%
- 3.6%
Profitability
- 40.5%
- 13.7%
- 12.1%
- –
- 21.5%
- 23.0%
- –
- –
- –
- –
Growth
- +4.7%
- –
- –
- –
- +0.0%
Financial health
- -1.4×
- 0.03
- –
- 44.2×
- 1.92
- –
- –
How it ranks in Materials
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 7%of 989
Top 39%of 954
Bottom 47%of 773
Top 49%of 933
Top 24%of 988
3.6%of the share price, paid each year
On $1,000 invested$36a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
81.7% of its profit
Room to growStretchedMore than it earns: 55.5%
News
Bayer gains approval of Factor XIa inhibitor asundexian to reduce stroke riskSeeking Alpha · Nov 10, 2026Bayer’s experimental PET tracer shows accuracy in Phase 3 cardiac amyloidosisSeeking Alpha · Aug 30, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
4/7Passes 4 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
77Pass
Benjamin Graham
58No pass
Philip Fisher
59No pass
Peter Lynch
60Pass
Joel Greenblatt
46No pass
Charlie Munger
77Pass
Terry Smith
71Pass
Questions about Bayer CropScience
Is Bayer CropScience a good stock to buy?
A solid business at a fair price. 4 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Bayer CropScience AI analysis
What does Bayer CropScience do?
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and hybrid corn seeds in India, Germany, Bangladesh, and internationally. It is in Agricultural Inputs, based in Thane, India.
Does Bayer CropScience pay a dividend?
Yes. At today's price the dividend is 3.6% a year, about 82% of its yearly profit. In 2026 it paid out ₹5.63 billion in dividends.
Is Bayer CropScience stock halal?
Yes. Bayer CropScience passes our halal screen: its business is permitted and its debt is 0.5% of its market value, under the 30% limit. How we check
How has Bayer CropScience stock done over the past year?
Down 20.6% over the past twelve months, to ₹3,473.70. It traded between ₹3,249.90 and ₹4,989.50 and is 30.4% below its high.
Who are Bayer CropScience's competitors?
The largest listed companies in the same industry are Nutrien, CF Industries Holdings, Industries Qatar Q.P.S.C. and Qinghai Salt Lake Industry Co.,Ltd. The peers table on this page compares their profit, growth and price with Bayer CropScience's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.